Repligen Corporation - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
RGEN Nasdaq 2836 www.repligen.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Repligen Corporation

Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair - Jan 6th, 2026 5:30 am
1 Cash-Heavy Stock to Target This Week and 2 Facing Challenges - Jan 5th, 2026 9:36 pm
3 Stocks Estimated To Be Trading Below Their Intrinsic Value In December 2025 - Dec 22nd, 2025 10:38 am
Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference - Dec 18th, 2025 5:30 am
Here’s Why Sands Capital Global Growth Fund Decided to Sell Repligen Corporation (RGEN) - Dec 17th, 2025 6:35 am
Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows - Dec 16th, 2025 5:30 am
The five-year earnings decline is not helping Repligen's (NASDAQ:RGEN share price, as stock falls another 3.3% in past week - Dec 9th, 2025 10:51 am
1 Volatile Stock to Target This Week and 2 We Turn Down - Dec 7th, 2025 9:35 pm
Why Is Exact Sciences (EXAS) Up 45.4% Since Last Earnings Report? - Dec 3rd, 2025 9:30 am
Repligen Corporation to Present at Evercore Healthcare Conference - Nov 26th, 2025 5:30 am
Why Repligen (RGEN) Stock Is Trading Up Today - Nov 21st, 2025 4:36 pm
Three Companies Estimated To Be Priced Below Their Intrinsic Value In November 2025 - Nov 12th, 2025 10:38 am
Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know - Nov 11th, 2025 1:56 pm
3 Cash-Producing Stocks We Approach with Caution - Nov 10th, 2025 9:33 pm
Drug Development Inputs & Services Stocks Q3 Recap: Benchmarking Repligen (NASDAQ:RGEN) - Nov 6th, 2025 8:31 pm
Repligen (RGEN): Assessing Valuation After Q3 Profits and Raised 2025 Guidance - Nov 5th, 2025 5:15 am
Repligen Corporation to Present at Upcoming November Conferences - Nov 4th, 2025 5:30 am
5 Revealing Analyst Questions From Repligen’s Q3 Earnings Call - Nov 3rd, 2025 10:32 pm
3 Hyped Up Stocks with Open Questions - Oct 29th, 2025 10:37 pm
RGEN'S Q3 Earnings Beat Estimates, Revenues Surge Y/Y, Stock Down - Oct 29th, 2025 9:18 am